PREVYMIS (letermovir)
ANTIVIRAL - CMV INFECTION·PREVENTION OF CMV DISEASE AFTER KIDNEY TRANSPLANTATION·+1
Merck Sharp & Dohme
Indication
Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant
Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant refers to prophylactic intervention against human cytomegalovirus (CMV) replication and associated clinical disease in severely immunocompromised transplant recipients. Read more about Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant
2 drugs 1 manufacturers
Drugs that treat it
Common Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant therapies.
PREVYMIS (letermovir)
ANTIVIRAL - CMV INFECTION·PREVENTION OF CMV DISEASE AFTER KIDNEY TRANSPLANTATION·+1
Merck Sharp & Dohme
Filter & compare in the drug finder →Opens the drug finder with Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPrevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant refers to prophylactic intervention against human cytomegalovirus (CMV) replication and associated clinical disease in severely immunocompromised transplant recipients.
In patients undergoing allogeneic hematopoietic stem cell transplantation, particularly those who are CMV-seropositive prior to conditioning, profound T-cell depletion and immunosuppressive therapy severely impair CMV-specific cell-mediated immunity.
This immunological deficit permits latent CMV to reactivate from cellular reservoirs, leading to systemic viremia and potential end-organ complications such as pneumonitis, enteritis, and hepatitis, as well as increased overall mortality.
Prophylaxis aims to maintain viral suppression and prevent progression to overt cytomegalovirus disease during the vulnerable post-engraftment recovery period.
- fda.gov
Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant refers to prophylactic intervention against human cytomegalovirus (CMV) replication and associated clinical disease in severely immunocompromised transplant recipients Prophylaxis aims to maintain viral suppression and prevent progression to overt cytomegalovirus disease during the vulnerable post-engraftment recovery period
- nih.gov
Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant refers to prophylactic intervention against human cytomegalovirus (CMV) replication and associated clinical disease in severely immunocompromised transplant recipients This immunological deficit permits latent CMV to reactivate from cellular reservoirs, leading to systemic viremia and potential end-organ complications such as pneumonitis, enteritis, and hepatitis, as well as increased overall mortality
- idse.net
In patients undergoing allogeneic hematopoietic stem cell transplantation, particularly those who are CMV-seropositive prior to conditioning, profound T-cell depletion and immunosuppressive therapy severely impair CMV-specific cell-mediated immunity Prophylaxis aims to maintain viral suppression and prevent progression to overt cytomegalovirus disease during the vulnerable post-engraftment recovery period
- nih.gov
In patients undergoing allogeneic hematopoietic stem cell transplantation, particularly those who are CMV-seropositive prior to conditioning, profound T-cell depletion and immunosuppressive therapy severely impair CMV-specific cell-mediated immunity This immunological deficit permits latent CMV to reactivate from cellular reservoirs, leading to systemic viremia and potential end-organ complications such as pneumonitis, enteritis, and hepatitis, as well as increased overall mortality
- lynchburg.edu
This immunological deficit permits latent CMV to reactivate from cellular reservoirs, leading to systemic viremia and potential end-organ complications such as pneumonitis, enteritis, and hepatitis, as well as increased overall mortality
- mednexus.org
Prophylaxis aims to maintain viral suppression and prevent progression to overt cytomegalovirus disease during the vulnerable post-engraftment recovery period
Personalize your experience
Follow Prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplant and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.